Prof. Dr. med. Christoph Schliemann

Current affiliations

Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)

Publications

Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears Kockwelp, Jacqueline; Thiele, Sebastian; Bartsch, Jannis; Haalck, Lars; Gromoll, Jörg; Schlatt, Stefan; Exeler, Rita; Bleckmann, Annalen; Lenz, Georg; Wolf, Sebastian; Steffen, Björn; Berdel, Wolfgang Eduard; Schliemann, Christoph; Risse, Benjamin; Angenendt, Linus (2024) In: Blood Advances, 8(1), 70-79. doi:10.1182/bloodadvances.2023011076 Research article (journal) \| Peer reviewed \| Published
Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations Shumilov, Evgenii; Mazzeo, Paolo; Ghandili, Susanne; Künstner, Axel; Weidemann, Sören; Banz, Yara; Ströbel, Philipp; Pollak, Matthias; Kolloch, Lina; Beltraminelli, Helmut; Kerkhoff, Andrea; Mikesch, Jan-Henrik; Schlimann, Christoph; Haase, Detlef; Wulf, Gerald; Legros, Myriam; Lenz, Georg; Feldmeyer, Laurence; Pabst, Thomas; Witte, Hanno; Gebauer, Niklas; Bacher, Ulrike (2024) In: Annals of Hematology, 103(5). Research article (journal) \| Peer reviewed \| Published
An overview and a roadmap for artificial intelligence in hematology and oncology Rösler W; Altenbuchinger M; Bae{ß}ler B; Beissbarth T; Beutel G; Bock R; Bubnoff N; Eckardt J; Foersch S; Loeffler CM; others (2023) In: Journal of Cancer Research and Clinical Oncology, 15, 1-10. Review article (journal) \| Peer reviewed \| Published
A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy Berdel AF, Koch R, Gerss J, Hentrich M, Peceny R, Bartscht T, Steffen B, Bischoff M, Spiekermann K, Angenendt L, Mikesch JH, Kewitz T, Butterfass-Bahloul T, Serve H, Lenz G, Berdel WE, Krug U, Schliemann C (2023) In: Annals of Hematology, 102, 63-72. doi:10.1007/s00277-022-05025-0 Research article (journal) \| Peer reviewed \| Published
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study Niederwieser D, Lang T, Krahl R, Heinicke T, Maschmeyer G, Al-Ali HK, Schwind S, Jentzsch M, Cross M, Kahl C, Wolf HH, Sayer H, Schulze A, Dreger P, Hegenbart U, Krämer A, Junghanss C, Mügge LO, Hähling D, Hirt C, Späth C, Peter N, Opitz B, Florschütz A, Reifenrath K, Zojer N, Scholl S, Pönisch W, Heyn S, Vucinic V, Hochhaus A, Aul C, Giagounidis A, Balleisen L, Oldenkott B, Staib P, Kiehl M, Schütte W, Naumann R, Eimermacher H, Dörken B, Sauerland C, Lengfelder E, Hiddemann W, Wörmann B, Müller-Tidow C, Serve H, Schliemann C, Hehlmann R, Berdel WE, Pfirrmann M, Krug U, Hoffmann VS (2023) In: Annals of Hematology, 102(3), 547-561. doi:10.1007/s00277-023-05087-8 Research article (journal) \| Peer reviewed \| Published

Show all publications

Projects

PHASE I STUDY OF tTF-NGR IN PATIENTS WITH RECURRENT OR REFRACTORY MALIGNANT TUMORS AND LYMPHOMAS BEYOND ALL STANDARD TREATMENTS (tTF-NGR) Duration: since 01/01/2017 Type of project: Own resources project
A single-arm, open label, multi-center phase I/II trial to assess the safety and efficacy of BIBF 1120 added to low-dose cytarabine in elderly patients with… (BIBF 1120) Duration: 01/01/2010 - 01/12/2020 Type of project: Own resources project

Prizes

Paper of the Month 2024 Awarded by: Medizinische Fakultät der Universität Münster Award given to: Kockwelp, Jacqueline; Thiele, Sebastian; Bartsch, Jannis; Haalck, Lars; Schliemann, Christoph; Risse, Benjamin; Angenendt, Linus Announced at: 15/03/2024 \| Date of awarding: 15/03/2024 Type of distinction: Best publication award
PHOENIX Pharmazie Wissenschaftspreis 2014 Awarded by: PHOENIX group Award given to: Berdel, Wolfgang; Schliemann, Christoph Date of awarding: 15/11/2014 Type of distinction: Best publication award
MTTC Award 2014 Awarded by: Deutsche Fortbildungsinitiative „Molecular Targeted Therapy of Cancer (MTTC)“ Award given to: Schliemann, Christoph; Gutbrodt, Katrin Announced at: 15/03/2014 \| Date of awarding: 15/03/2014 Type of distinction: Best publication award

Doctorates

Untersuchung zur in-vitro-Toxizität eines Inhibitors der Aurorakinase A/B, von Vincristin und Paclitaxel an einem Panel von 18 ausgewählten pädiatrischen Tumor…
Candidate: Bröckling, Sebastian | Supervisors: Boos, Joachim; Schliemann, Christoph; Lanvers-Kaminsky, Claudia
Period of time: until 20/08/2015
Doctoral examination procedure finished at: Doctoral examination procedure at University of Münster

Expression der Angiopoietine und ihres Rezeptors Tie-2 im Knochenmark von Patienten mit akuter Myeloischer Leukämie
Candidate: Schliemann, Christoph | Supervisors: Mesters, Rolf
Period of time: until 04/04/2005
Doctoral examination procedure finished at: Doctoral examination procedure at University of Münster

Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears Kockwelp, Jacqueline; Thiele, Sebastian; Bartsch, Jannis; Haalck, Lars; Gromoll, Jörg; Schlatt, Stefan; Exeler, Rita; Bleckmann, Annalen; Lenz, Georg; Wolf, Sebastian; Steffen, Björn; Berdel, Wolfgang Eduard; Schliemann, Christoph; Risse, Benjamin; Angenendt, Linus (2024) In: Blood Advances, 8(1), 70-79. doi:10.1182/bloodadvances.2023011076 Research article (journal) \| Peer reviewed \| Published
Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations Shumilov, Evgenii; Mazzeo, Paolo; Ghandili, Susanne; Künstner, Axel; Weidemann, Sören; Banz, Yara; Ströbel, Philipp; Pollak, Matthias; Kolloch, Lina; Beltraminelli, Helmut; Kerkhoff, Andrea; Mikesch, Jan-Henrik; Schlimann, Christoph; Haase, Detlef; Wulf, Gerald; Legros, Myriam; Lenz, Georg; Feldmeyer, Laurence; Pabst, Thomas; Witte, Hanno; Gebauer, Niklas; Bacher, Ulrike (2024) In: Annals of Hematology, 103(5). Research article (journal) \| Peer reviewed \| Published
An overview and a roadmap for artificial intelligence in hematology and oncology Rösler W; Altenbuchinger M; Bae{ß}ler B; Beissbarth T; Beutel G; Bock R; Bubnoff N; Eckardt J; Foersch S; Loeffler CM; others (2023) In: Journal of Cancer Research and Clinical Oncology, 15, 1-10. Review article (journal) \| Peer reviewed \| Published
A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy Berdel AF, Koch R, Gerss J, Hentrich M, Peceny R, Bartscht T, Steffen B, Bischoff M, Spiekermann K, Angenendt L, Mikesch JH, Kewitz T, Butterfass-Bahloul T, Serve H, Lenz G, Berdel WE, Krug U, Schliemann C (2023) In: Annals of Hematology, 102, 63-72. doi:10.1007/s00277-022-05025-0 Research article (journal) \| Peer reviewed \| Published
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study Niederwieser D, Lang T, Krahl R, Heinicke T, Maschmeyer G, Al-Ali HK, Schwind S, Jentzsch M, Cross M, Kahl C, Wolf HH, Sayer H, Schulze A, Dreger P, Hegenbart U, Krämer A, Junghanss C, Mügge LO, Hähling D, Hirt C, Späth C, Peter N, Opitz B, Florschütz A, Reifenrath K, Zojer N, Scholl S, Pönisch W, Heyn S, Vucinic V, Hochhaus A, Aul C, Giagounidis A, Balleisen L, Oldenkott B, Staib P, Kiehl M, Schütte W, Naumann R, Eimermacher H, Dörken B, Sauerland C, Lengfelder E, Hiddemann W, Wörmann B, Müller-Tidow C, Serve H, Schliemann C, Hehlmann R, Berdel WE, Pfirrmann M, Krug U, Hoffmann VS (2023) In: Annals of Hematology, 102(3), 547-561. doi:10.1007/s00277-023-05087-8 Research article (journal) \| Peer reviewed \| Published